The Vita Coco Company

COCONASDAQUSD

THESIS ALERT

Email me when the COCO thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$65.36
−$0.55 (−0.83%)Today 1M +11.94%

Updated Nov 11, 10:20 AM ET · Regular session · May be delayed

—
Source valuation snapshot. Not a live recalculation.
—
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
—
Diluted earnings per share from the latest filed annual.
$65.91
Prior regular-session close from the quote source.
$64.74–$66.40
Regular-session low and high so far today.
99.1K
Regular-session shares traded · Nov 11, 10:20 AM ET.
Feb 17 projected
Projected for 2027-02-17 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$41.50–$85.83
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own COCO if Vita Coco converts leadership in packaged coconut water, broad retail distribution and an asset-light global supply base into predictable, above-market growth and cash generation — provided it preserves pricing/margins against tariff and competitive pressure.

COCO price history

LATEST PRICE$65.36TODAY−$0.55 (-0.83%)
COCO +13.92%S&P 500 -2.93%Since first plotted close
4 hours

Loading recent earnings…

INVESTMENT THESIS

What must happen next

4 MATERIAL PROPOSITIONS
  • Vita Coco’s U.S. category leadership and broad retail distribution will sustain above‑market revenue growth because brand preference plus multi‑channel placement limits churn to competitors and supports pricing.StrengtheningMateriality: High

    Revenue rose from $427.8M (2022) to $609.8M (2025), with 18.2% year-over-year growth in 2025. If true, revenue growth funds product expansion and justifies the premium valuation; if false, growth and valuation will slip as volume and pricing weaken.

    Watch: A major CPG incumbent (e.g., Coca-Cola or PepsiCo) launching/marketing a national coconut/plant water at scale and winning shelf distribution or pricing.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Revenue rose from $427.8M (2022) to $609.8M (2025), with 18.2% year-over-year growth in 2025.

    Open source ↗
  • The asset‑light, diversified sourcing network and ability to shift volume between ~16 factories across six countries will limit permanent gross‑margin damage from episodic shipping or tariff shocks, preventing sustained COGS-driven margin collapse.HoldingMateriality: High

    Gross profit increased from $103.4M (2022) to $222.6M (2025) and gross margins stayed in the mid-30s across 2023-2025. If sourcing flexibility contains input-cost shocks, gross margins and gross_profit recover after temporary hits; if not, persistent cost inflation will compress profitability regardless of growth.

    Watch: Sustained or higher reciprocal tariffs (beyond Nov 2025 relief) or long duration ocean‑freight disruption (e.g., Red Sea/Gulf of Aden security issues) that prevent sourcing shifts.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Gross profit increased from $103.4M (2022) to $222.6M (2025) and gross margins stayed in the mid-30s across 2023-2025.

    Open source ↗
  • Private‑label and bulk supply contracts provide volume stability and a predictable revenue base that helps convert sales into operating cash flow even when branded growth is variable.StrengtheningMateriality: Medium

    Operating cash flow was positive across recent years (–$10.9M in 2022 to $107.2M in 2023, $42.9M in 2024, $47.2M in 2025), showing ability to generate cash. If private‑label demand persists, cash flow supports reinvestment and reduces execution risk; if retailers drop contracts or insource, cash generation and resilience will fall.

    Watch: Loss of one or more material private‑label contracts or a major customer moving to an alternate supplier or in‑house production.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating cash flow was positive across recent years (–$10.9M in 2022 to $107.2M in 2023, $42.9M in 2024, $47.2M in.

    Open source ↗
  • Scale in sourcing, co‑packing and distribution should allow operating income to expand with revenue (operating leverage), because fixed SG&A and sales/distribution investments spread over a larger base.StrengtheningMateriality: Medium

    Operating income grew from $3.1M (2022) to $56.5M (2023) to $73.8M (2024) and $82.5M (2025), reflecting margin recovery and scale. If operating leverage holds, earnings and free cash flow will compound faster than revenue; if SG&A or trade spend must rise to defend share, operating income will be pressured despite revenue growth.

    Watch: Sustained higher trade promotions or increased marketing spend required to defend/expand share against large CPG entrants.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating income grew from $3.1M (2022) to $56.5M (2023) to $73.8M (2024) and $82.5M (2025), reflecting margin recovery and scale.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Vita Coco’s U.S. category leadership and broad retail distribution will sustain above‑market revenue growth because brand preference plus multi‑channel placement limits churn to competitors and supports pricing. If true, revenue growth funds product expansion and justifies the premium valuation; if false, growth and valuation will slip as volume and pricing weaken.

The asset‑light, diversified sourcing network and ability to shift volume between ~16 factories across six countries will limit permanent gross‑margin damage from episodic shipping or tariff shocks, preventing sustained COGS-driven margin collapse. If sourcing flexibility contains input-cost shocks, gross margins and gross_profit recover after temporary hits; if not, persistent cost inflation will compress profitability regardless of growth.

Private‑label and bulk supply contracts provide volume stability and a predictable revenue base that helps convert sales into operating cash flow even when branded growth is variable. If private‑label demand persists, cash flow supports reinvestment and reduces execution risk; if retailers drop contracts or insource, cash generation and resilience will fall.

Scale in sourcing, co‑packing and distribution should allow operating income to expand with revenue (operating leverage), because fixed SG&A and sales/distribution investments spread over a larger base. If operating leverage holds, earnings and free cash flow will compound faster than revenue; if SG&A or trade spend must rise to defend share, operating income will be pressured despite revenue growth.

All standing thesis claims
Original report summary

Vita Coco converts leadership in packaged coconut water, broad retail distribution and an asset-light global supply base into predictable, above-market growth and cash generation — provided it preserves pricing/margins against tariff and competitive pressure.

Evidence assessed Nov 8, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

BULL CASE / BEAR CASE

Bull case and bear case for Vita Coco Company

Where the evidence on Vita Coco Company stands: Holding on the latest evidence (Nov 8, 2026). Of its 4 thesis points, 3 strengthening and 1 holding.

Bull case: what the evidence supports

  • Vita Coco’s U.S. category leadership and broad retail distribution will sustain above‑market revenue growth because brand preference plus multi‑channel placement limits churn to competitors and supports pricing.

    sec.gov ↗

  • The asset‑light, diversified sourcing network and ability to shift volume between ~16 factories across six countries will limit permanent gross‑margin damage from episodic shipping or tariff shocks, preventing sustained COGS-driven margin collapse.

    sec.gov ↗

  • Private‑label and bulk supply contracts provide volume stability and a predictable revenue base that helps convert sales into operating cash flow even when branded growth is variable.

    sec.gov ↗

  • Scale in sourcing, co‑packing and distribution should allow operating income to expand with revenue (operating leverage), because fixed SG&A and sales/distribution investments spread over a larger base.

    sec.gov ↗

Bear case: what would count against it

  • A major CPG incumbent (e.g., Coca-Cola or PepsiCo) launching/marketing a national coconut/plant water at scale and winning shelf distribution or pricing.

    sec.gov ↗

  • Sustained or higher reciprocal tariffs (beyond Nov 2025 relief) or long duration ocean‑freight disruption (e.g., Red Sea/Gulf of Aden security issues) that prevent sourcing shifts.

    sec.gov ↗

  • Loss of one or more material private‑label contracts or a major customer moving to an alternate supplier or in‑house production.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Vita Coco Company

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed Vita Coco Company’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. MIXED
    Reported results of operations (earnings release).

    Vita Coco Company filed an SEC 8-K on 2026-10-22: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. MIXED
    Reported results of operations (earnings release).

    Vita Coco Company filed an SEC 8-K on 2026-07-23: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. MIXED
    Completed an acquisition or disposition of assets.

    Vita Coco Company filed an SEC 8-K on 2026-07-22: Completed an acquisition or disposition of assets. It is a dated development that tests the current thesis.

RISKS / FALSIFIERS

What could break the thesis

  • A major CPG incumbent (e.g., Coca-Cola or PepsiCo) launching/marketing a national coconut/plant water at scale and winning shelf distribution or pricing.
  • Sustained or higher reciprocal tariffs (beyond Nov 2025 relief) or long duration ocean‑freight disruption (e.g., Red Sea/Gulf of Aden security issues) that prevent sourcing shifts.
  • Loss of one or more material private‑label contracts or a major customer moving to an alternate supplier or in‑house production.
  • Sustained higher trade promotions or increased marketing spend required to defend/expand share against large CPG entrants.

COCO news

Loading headlines…

FINANCIAL STATEMENTS

COCO income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

COCO: quick answers

When does Vita Coco Company (COCO) report earnings next?
Vita Coco Company's next results are projected for February 17, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 22, 2026. Earnings calendar
What is COCO's short interest?
As of October 30, 2026, 7.1M COCO shares were sold short, up 2.7% from the count before. At the stock's average daily volume that is 4.4 days to cover. FINRA publishes the count twice a month. COCO short interest history
Have members of Congress traded COCO?
Reports made public in the last 90 days disclose 3 trades in COCO by 2 filers: 2 purchases and 1 sale. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed COCO trade
Which well-known investors own COCO?
2 of the 37 well-known funds tracked here reported COCO shares in their latest 13F filings. By share of the fund's portfolio: Maverick Capital, 0.0%; Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios

COCO in well-known investors’ portfolios

2 of 37 funds reported COCO shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Maverick Capital0.03%$3.4M−32.9%Q2 2026
Ray DalioBridgewater Associates0.00%$241KNewQ2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.